Hepatic embolization for Cushing syndrome from metastatic tumors: a single-center case series
Hepatic embolization is a viable palliative option for CS due to unresectable liver-dominant metastases, providing meaningful biochemical improvement with acceptable safety and supporting integration into multidisciplinary CS management.
Authors
- Jorge Esteban Mosquera
- Clive Musonza (ORCID: https://orcid.org/0000-0002-0773-9209)
- Jessica Abramowitz (ORCID: https://orcid.org/0000-0002-0391-7207)
- S. Zhang
- Anil Pillai
- Salwan Al Mutar (ORCID: https://orcid.org/0009-0005-3557-7525)
- Waddah Arafat
- Oksana Hamidi
- Patricio M Polanco
- Sasan Mirfakhraee
Institutions
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1210/jendso/bvag046
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases